Recombinant Proteins

Recombinant proteins are available as monomers, dimers, trimers, and multimers. Full-length and partial-length proteins are available for control experiments, assay development, and antibody development projects. Utilization of E.coli, mammalian, yeast, and baculovirus expression systems with various activity assays performed to ensure functionality. Applications include  CLIA, EIA, IM, Lateral Flow, and WB.

Thousands of recombinant proteins are available with custom protein expression services available for difficult or hard-to-source targets.

Product Type
Research Area
Host Species
Species Reactivity
Tested Applications
SARS-CoV-2 (COVID-19) NSP2 Recombinant Protein
List Size:
0.1 mg
SARS-CoV-2 (COVID-19) NSP2 Recombinant Protein
List Size:
0.1 mg
SARS-CoV-2 (COVID-19) NSP3 (743 - 1072) Recombinant Protein
List Size:
0.1 mg
SARS-CoV-2 (COVID-19) NSP3 (743 - 1072) Recombinant Protein
List Size:
0.1 mg
SARS-CoV-2 (COVID-19) NSP3 Recombinant Protein
List Size:
0.1 mg
SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein
List Size:
0.1 mg
SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein
List Size:
0.1 mg
SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein
List Size:
0.1 mg
SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein
List Size:
0.1 mg
SARS-CoV-2 (COVID-19) NSP7 Recombinant Protein
List Size:
0.1 mg